CRIS Current Research Information System

PANTALEO, MARIA ABBONDANZA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.013
AS - Asia 10.246
EU - Europa 9.153
AF - Africa 871
SA - Sud America 663
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 5
Totale 34.971
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.863
SG - Singapore 3.370
CN - Cina 3.110
GB - Regno Unito 2.006
IT - Italia 1.842
VN - Vietnam 1.697
DE - Germania 1.099
SE - Svezia 1.094
HK - Hong Kong 737
RU - Federazione Russa 571
IN - India 566
BR - Brasile 450
IE - Irlanda 398
FR - Francia 379
CH - Svizzera 371
UA - Ucraina 294
KR - Corea 281
NL - Olanda 277
CI - Costa d'Avorio 263
TG - Togo 215
ZA - Sudafrica 193
FI - Finlandia 189
EE - Estonia 163
JP - Giappone 120
AT - Austria 99
SC - Seychelles 95
AR - Argentina 94
CA - Canada 94
BG - Bulgaria 85
JO - Giordania 82
ID - Indonesia 78
PL - Polonia 69
NG - Nigeria 66
BE - Belgio 60
MX - Messico 37
GR - Grecia 33
IR - Iran 30
EC - Ecuador 29
ES - Italia 29
CL - Cile 26
BD - Bangladesh 24
TR - Turchia 23
IQ - Iraq 20
PY - Paraguay 19
AU - Australia 17
CO - Colombia 16
MY - Malesia 16
PK - Pakistan 16
LT - Lituania 15
HR - Croazia 14
RO - Romania 13
PE - Perù 12
LB - Libano 10
UZ - Uzbekistan 10
SK - Slovacchia (Repubblica Slovacca) 9
CZ - Repubblica Ceca 8
UY - Uruguay 8
EG - Egitto 7
SA - Arabia Saudita 7
DZ - Algeria 6
IL - Israele 6
NO - Norvegia 6
PT - Portogallo 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
DK - Danimarca 5
KE - Kenya 5
MU - Mauritius 5
NI - Nicaragua 5
VE - Venezuela 5
AO - Angola 4
HU - Ungheria 4
LA - Repubblica Popolare Democratica del Laos 4
PH - Filippine 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
DO - Repubblica Dominicana 3
MA - Marocco 3
NP - Nepal 3
NZ - Nuova Zelanda 3
AL - Albania 2
AZ - Azerbaigian 2
GE - Georgia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MD - Moldavia 2
MQ - Martinica 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
YE - Yemen 2
AF - Afghanistan, Repubblica islamica di 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
DM - Dominica 1
ET - Etiopia 1
Totale 34.948
Salva come PNG Salva come JPEG
Città #
Singapore 2.222
Southend 1.784
Ashburn 1.657
Fairfield 1.462
Chandler 1.165
Woodbridge 736
Hong Kong 727
Wilmington 674
Houston 662
Hefei 655
Seattle 619
Santa Clara 570
Cambridge 497
Bologna 490
Princeton 488
Dong Ket 458
Ann Arbor 443
Beijing 439
Dublin 398
Bern 345
Boardman 312
Seoul 274
Abidjan 263
Ho Chi Minh City 259
Lomé 215
Dallas 206
Nanjing 203
Westminster 195
Hanoi 193
Redmond 184
New York 177
Los Angeles 172
Padova 159
Berlin 156
Jacksonville 153
Helsinki 127
Jinan 110
Milan 106
Tokyo 104
Buffalo 102
Redondo Beach 95
Turin 90
San Diego 86
Sofia 85
Amman 81
Shenyang 81
Munich 75
Saint Petersburg 75
Rome 69
Changsha 66
Nanchang 65
Frankfurt am Main 63
Abeokuta 61
Bengaluru 60
Hebei 60
São Paulo 60
Medford 59
Vienna 59
Brussels 58
Jakarta 57
Falls Church 56
Guangzhou 54
Warsaw 54
Des Moines 53
Zhengzhou 49
Bremen 48
Jiaxing 48
Shanghai 47
Toronto 46
Tianjin 43
Dearborn 42
Chicago 41
Lappeenranta 41
Florence 40
Hyderabad 40
Hangzhou 39
London 39
Mülheim 39
Yubileyny 39
Phoenix 38
Olalla 36
Haiphong 33
Kuban 33
Nuremberg 33
Norwalk 30
Amsterdam 28
Falkenstein 28
Redwood City 28
Taizhou 28
Biên Hòa 27
Tongling 27
Taiyuan 26
Fremont 25
Ningbo 25
San Francisco 25
Bühl 24
Orem 24
Cesena 21
Denver 21
Montreal 21
Totale 23.005
Salva come PNG Salva come JPEG
Nome #
Follow-up del cancro del pancreas esocrino 402
Good performance of platinum-based chemotherapy for high-grade gastroenteropancreatic and unknown primary neuroendocrine neoplasms 365
SUSTAINED COMPLETE RESPONSE OF ADVANCED HEPATOCELLULAR CARCINOMA WITH METRONOMIC CAPECITABINE: A REPORT OF THREE CASES 265
A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and high-resolution genomic copy number. 241
Circadian variations of rectal cell proliferation in patients affected by advanced colorectal cancer. 238
Cardiac metastasis of melanoma. 231
Adjuvant chemotherapy for resected colorectal cancer metastases: literature revision and meta-analysis 231
A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach 230
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases. 227
Brain Metastases from Biliary Tract Cancer: A Monocentric Retrospective Analysis of 450 Patients 217
18F-FDG-PET/CT imaging in cardiac tumors: illustrative clinical cases and review of the literature. 211
Molecular modelling evaluation of exon 18 His845_Asn848delinsPro pDGFRα mutation in a metastatic GIST patient responding to imatinib 209
Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST. 208
A distinct pediatric-type gastrointestinal stromal tumor in adults: potential role of succinate dehydrogenase subunit A mutations. 206
Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments 202
Biliary stone disease in patients receiving somatostatin analogs for neuroendocrine neoplasms. A retrospective observational study 200
Chronic therapy in gastrointestinal stromal tumours (GISTs): the big gap between theory and practice 199
Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients 198
Analysis of microbiome in gastrointestinal stromal tumors: Looking for different players in tumorigenesis and novel therapeutic options 197
Hippo pathway targeting in TP53-mutant Uterine Leiomyosarcoma 194
Concurrent EGFr and Cox-2 expression in colorectal cancer: proliferation impact and tumour spreading 192
Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations 192
An exploratory association of polymorphisms in angiogenesis-related genes with susceptibility, clinical response and toxicity in gastrointestinal stromal tumors receiving sunitinib after imatinib failure 190
Clinical relevance of circulating molecules in cancer: focus on gastrointestinal stromal tumors 189
Genome-wide analysis identifies MEN1 and MAX mutations and a neuroendocrine-like molecular heterogeneity in Quadruple WT GIST 187
Whole Exome Sequencing Uncovers Germline Variants of Cancer-Related Genes in Sporadic Pheochromocytoma 186
Alternative schedules or integration strategies to maximise treatment duration with sunitinib in patients with gastrointestinal stromal tumours. 185
Cell proliferation and ultrastructural changes of the duodenal mucosa of patients affected by familial adenomatous polyposis. 184
Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model. 184
Clinical, radiological and biological features of lung metastases in gastrointestinal stromal tumors (case reports). 182
Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST) 182
Complete remission of primary colon cancer in a metastatic patient treated with CPT-11 plus capecitabine. 182
Combined treatment strategies in gastrointestinal stromal tumors (GISTs) after imatinib and sunitinib therapy. 181
Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases. 181
Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer 180
Diagnostic Accuracy of Cardiac Computed Tomography and 18F-Fluorodeoxyglucose With Positron Emission Tomography in Cardiac Masses 180
Risk of duodenal adenomas in familial adenomatous polyposis to progress toward advanced neoplastic disease 179
MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. 176
Duration of adjuvant treatment following radical resection of metastases from gastrointestinal stromal tumours. 176
The rs17084733 variant in the KIT 3’ UTR disrupts a miR-221/222 binding site in gastrointestinal stromal tumour: a sponge-like mechanism conferring disease susceptibility 176
Development of a Nephrotic Syndrome in a Patient with Gastrointestinal Stromal Tumor during a Long-Time Treatment with Sunitinib. 175
Late recurrences of gastrointestinal stromal tumours (GISTs) after 5 years of follow-up. 175
Activity of sunitinib in extraskeletal myxoid chondrosarcoma. 175
Integrated Molecular Characterization of Gastrointestinal Stromal Tumors (GIST) Harboring the Rare D842V Mutation in PDGFRA Gene. 174
Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST) 173
Mechanisms of secondary resistance to tyrosine kinase inhibitors in gastrointestinal stromal tumours (Review). 171
ACTIVATED NF-KB IN COLORECTAL CANCER: PREDICTIVE OR PROGNOSTIC FACTOR? 171
In Reply 171
An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor 171
Successful multidisciplinary clinical approach and molecular characterization by whole transcriptome sequencing of a cardiac myxofibrosarcoma: A case report 170
Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST 169
Gene duplication, rather than epigenetic changes, drives FGF4 overexpression in KIT/PDGFRA/SDH/RAS-P WT GIST 169
Genomic Characterization of Rare Primary Cardiac Sarcoma Entities 168
Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET. 168
Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment 168
Mechanisms of resistance to a PI3K inhibitor in gastrointestinal stromal tumors: an omic approach to identify novel druggable targets 167
miRNA Expression May Have Implications for Immunotherapy in PDGFRA Mutant GISTs 165
Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies 165
Severe esophagitis in a patient with gastrointestinal stromal tumor treated with imatinib. 165
An immunohistochemical study of potential diagnostic and therapeutic biomarkers of wild type gastrointestinal stromal tumours - Letter to the editor. 164
Differential expression of neural markers in KIT and PDGFRA wild-type gastrointestinal stromal tumours. 163
Expanding the Spectrum of BRAF Non-V600E Mutations in Thyroid Nodules: Evidence-Based Data from a Tertiary Referral Centre 162
Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice 162
HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma 162
Neoadjuvant therapy for resectable pancreatic adenocarcinoma: An interim report of a prospective randomized study 161
Discovery of new potential actionable mutations in pancreatic ductal adenocarcinoma by next generation sequencing 160
Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice 160
Efficacy and biological activity of imatinib in metastatic Dermatofibrosarcoma Protuberans (DFSP) 160
Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma 159
Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer 159
Insulin-like growth factor 1 receptor expression in wild-type GISTs: a potential novel therapeutic target. 159
Identification of an actionable mutation of kit in a case of extraskeletal myxoid chondrosarcoma 158
Genetic Characterization of Cancer of Unknown Primary Using Liquid Biopsy Approaches 158
Molecular imaging suggests efficacy of bevacizumab beyond the second line in advanced colorectal cancer patients. 156
Laparoscopic treatment of gastric GIST: report of 21 cases and literature's review. 156
MicroRNA profile in gastrointestinal stromal tumors (GISTs) and correlation with KIT/PDGFRA kinase genotype. 155
Spontaneous regression of a desmoid intraabdominal tumor in a patient affected by familial adenomatous polyposis. 154
11C-acetate PET for early prediction of sunitinib response in metastatic renal cell carcinoma. 154
Postsorafenib systemic treatments for hepatocellular carcinoma: Questions and opportunities after the regorafenib trial 154
The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation 153
Integrating miRNA and gene expression profiling analysis revealed regulatory networks in gastrointestinal stromal tumors 152
Successful treatment with personalized dosage of imatinib in elderly patients with gastrointestinal stromal tumors 152
Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib 152
An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST) 152
Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunction. 150
Evaluation of Modified PEG-Anilinoquinazoline Derivatives as Potential Agents for EGFR Imaging in Cancer by Small Animal PET. 148
Efficacy of weekly docetaxel in locally advanced cardiac angiosarcoma 148
Capecitabine(CAP) based regimens vs infusional 5FU/AF in metastatic colorectal cancer cost/effectivness: the differences across the atlantic ocean 148
Microscopic margins of resection influence primary gastrointestinal stromal tumor survival. 147
SDHA Germline Mutations in SDH-Deficient GISTs: A Current Update 146
Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy. Review 146
Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response 146
Comparative Assessment of Antitumor Effects and Autophagy Induction as a Resistance Mechanism by Cytotoxics and EZH2 Inhibition in INI1-Negative Epithelioid Sarcoma Patient-Derived Xenograft 146
Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives. 145
Successful radiotherapy for local control of progressively increasing metastasis of gastrointestinal stromal tumor. 144
Gastrointestinal stromal tumors: report of an audit and review of the literature. 144
Genomic Landscape Comparison of Cardiac versus Extra-Cardiac Angiosarcomas 143
Personalized Medicine in Gastrointestinal Stromal Tumor (GIST): Clinical Implications of the Somatic and Germline DNA Analysis 142
Gene Expression Profiling of PDGFRA Mutant GIST Reveals Immune Signatures as a Specific Fingerprint of D842V Exon 18 Mutation 142
Molecular Imaging of EGFR: It's Time to Go Beyond Receptor Expression 141
Totale 17.828
Salva come PNG Salva come JPEG
Categoria #
all - tutte 102.422
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.422
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.072 0 0 0 0 0 164 50 148 427 169 159 955
2021/20224.637 487 183 229 367 388 211 108 395 256 277 968 768
2022/20235.399 587 782 291 634 325 352 153 323 859 172 398 523
2023/20241.665 169 262 89 185 132 301 85 122 60 84 86 90
2024/20256.067 294 802 534 440 933 287 478 257 114 427 311 1.190
2025/20267.450 1.485 1.279 1.297 1.092 1.544 753 0 0 0 0 0 0
Totale 35.794